Portal Hypertension News

Idiopathic portal hypertension patients who experienced variceal bleeding or were HIV-infected had an increased risk for portal vein thrombosis, according to data from a recent study.

Members of the All-Party Parliamentary Hepatology Group have asked the National Health Service in the United Kingdom to show more concern about the rise of liver disease.

Liver transplant patients with recurrent hepatitis C virus displayed less fibrotic progression when treated with tacrolimus, azathioprine and steroids compared with those patients receiving tacrolimus monotherapy in a recent study.

SAN DIEGO — Most patients with cirrhosis and portal vein thrombosis experienced either complete recanalization or marked improvement after placement of a transjugular portosystemic shunt in a study presented at the American College of Gastroenterology Annual Scientific Meeting.

Patients with alcoholic cirrhosis and severe vitamin D deficiency are at a greater risk for death and more likely to have severe cirrhosis and experience portal hypertension-related complications, according to data presented at the International Liver Congress in Amsterdam.

Patients with cirrhosis treated with beta-blockers experienced improved intestinal permeability and reduced bacterial translocation, reducing the risk for variceal bleeding, in a study presented at The International Liver Congress in Amsterdam.

Characteristics of collateral vessels, particularly flow volume in the largest vessel, are predictive factors for developing portal vein thrombosis, according to recent results.

Results from a recent study suggest that measurement of spleen stiffness can be a noninvasive method of assessing portal hypertension and detecting esophageal varices in patients with HCV-induced cirrhosis.

Obese patients who underwent liver transplant were more likely to have developed portal vein thrombosis before the procedure compared with nonobese patients in a recent study.

Patients with nonalcoholic fatty liver disease often had indications of portal hypertension and esophageal varices, most commonly among those with advanced fibrosis, in a recent study.